BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23812463)

  • 1. Lack of transparency of clinical trials on endometriosis.
    Guo SW; Evers JLH
    Obstet Gynecol; 2013 Jun; 121(6):1281-1290. PubMed ID: 23812463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the current status of clinical trials on endometriosis: issues and concerns.
    Guo SW
    Fertil Steril; 2014 Jan; 101(1):183-190.e4. PubMed ID: 24112527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
    Ross JS; Mulvey GK; Hines EM; Nissen SE; Krumholz HM
    PLoS Med; 2009 Sep; 6(9):e1000144. PubMed ID: 19901971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis?
    Guo SW; Groothuis PG
    Hum Reprod Update; 2018 Sep; 24(5):577-598. PubMed ID: 29893860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
    Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
    BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
    Roumiantseva D; Carini S; Sim I; Wagner TH
    Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
    Gresham G; Meinert JL; Gresham AG; Meinert CL
    JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A call for more transparency of registered clinical trials on endometriosis.
    Guo SW; Hummelshoj L; Olive DL; Bulun SE; D'Hooghe TM; Evers JL
    Hum Reprod; 2009 Jun; 24(6):1247-54. PubMed ID: 19264712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.
    Baudart M; Ravaud P; Baron G; Dechartres A; Haneef R; Boutron I
    BMC Med; 2016 Jan; 14():7. PubMed ID: 26819213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis.
    Krauth D; Anglemyer A; Philipps R; Bero L
    PLoS Biol; 2014 Jan; 12(1):e1001770. PubMed ID: 24465178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Trial Outcomes in Urology: Assessing Early Discontinuation, Results Reporting and Publication in ClinicalTrials.Gov Registrations 2007-2019.
    Magnani CJ; Steinberg JR; Harmange CI; Zhang X; Driscoll C; Bell A; Larson J; You JG; Weeks BT; Hernandez-Boussard T; Turner BE; Brooks JD
    J Urol; 2021 Apr; 205(4):1159-1168. PubMed ID: 33079618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Publication Rates of Registered Corneal Trials on ClinicalTrials.gov.
    Cehelyk EK; Crespo MA; Syed ZA
    Cornea; 2024 Mar; 43(3):356-359. PubMed ID: 37404122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 15. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
    Ohnmeiss DD
    Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfinished business: Terminated cancer trials and the relevance of treatment intent, sponsors and intervention types.
    Buergy D; Riedel J; Sarria GR; Ehmann M; Scafa D; Grilli M; Wenz F; Hofheinz RD
    Int J Cancer; 2021 Apr; 148(7):1676-1684. PubMed ID: 33045097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
    Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
    JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations.
    Smith SM; Wang AT; Pereira A; Chang DR; McKeown A; Greene K; Rowbotham MC; Burke LB; Coplan P; Gilron I; Hertz SH; Katz NP; Lin AH; McDermott MP; Papadopoulos EJ; Rappaport BA; Sweeney M; Turk DC; Dworkin RH
    Pain; 2013 Dec; 154(12):2769-2774. PubMed ID: 23962590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology.
    Ramsey S; Scoggins J
    Oncologist; 2008 Sep; 13(9):925-9. PubMed ID: 18794216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-publication and delayed publication of randomized trials on vaccines: survey.
    Manzoli L; Flacco ME; D'Addario M; Capasso L; De Vito C; Marzuillo C; Villari P; Ioannidis JP
    BMJ; 2014 May; 348():g3058. PubMed ID: 24838102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.